The different roles of TILs in ER + /HER2− compared with those in HER2 + or TN breast cancers seem to stem from the composition of subsets of T cells, including FOXP3 + T cells, which are more abundant in ER + than in ER- breast cancers [19]. This evidence concerns the gene ESR1 and breast cancer.